Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
Studying drug−protein interactions has gained significant attention lately, and this is because the majority of drugs interact with proteins, thereby altering their structure and, moreover, their functionality. Rivastigmine tartrate (RT) is a drug that is in use for mild to moderate Alzhei...
Main Authors: | Anas Shamsi, Taj Mohammad, Mohd Shahnawaz Khan, Moyad Shahwan, Fohad Mabood Husain, Md. Tabish Rehman, Md. Imtaiyaz Hassan, Faizan Ahmad, Asimul Islam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/9/495 |
Similar Items
-
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
by: Anas Shamsi, et al.
Published: (2020-05-01) -
Re‐evaluation of l(+)‐tartaric acid (E 334), sodium tartrates (E 335), potassium tartrates (E 336), potassium sodium tartrate (E 337) and calcium tartrate (E 354) as food additives
by: EFSA Panel on Food Additives and Flavourings (FAF), et al.
Published: (2020-03-01) -
Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles
by: Sara Salatin, et al.
Published: (2017-01-01) -
Aerobic L-tartrate Utilization by Bacillus Isolates
by: Disha Patel, et al.
Published: (2019-12-01) -
Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease
by: Davide V Moretti, et al.
Published: (2014-07-01)